Related Experiment Videos
The Interstitial Cystitis Association of America: lessons learned over the past 30 years
1Founder and President Emeritus, Interstitial Cystitis Association of America, USA.
Abstract:
In 1984, interstitial cystitis (IC) was considered a rare psychosomatic disorder in post-menopausal women. In 2014, the Interstitial Cystitis Association of America (ICA) celebrated its 30(th) anniversary. We've come a long way since 1984 and great progress has been made. IC is now recognized as a condition that afflicts both men and women of all ages, including children and teenagers. It is not a psychiatric disorder. Though it was once thought to be an orphan disease (defined as affecting less than 200,000 people), we now know that there are millions of women and men who suffer from IC/BPS (bladder pain syndrome). In looking back over this period, there were seven key reasons why the ICA became so successful: an extremely dedicated ICA staff, Board of Directors and volunteers; a very strong Medical Advisory Board and participation of many other urologists from across the country and around the world; cooperation of the media; epidemiological studies; the ICA's Pilot Research Program; our representation in Congress; and a strong working partnership with the National Institutes of Health (NIH). Our history may prove useful to other advocacy groups.
Insights
Interstitial cystitis (IC), now known as bladder pain syndrome (BPS), has evolved from a rare disorder to a widely recognized condition affecting millions. Advocacy efforts, research, and collaboration have been key to this progress.
Area of Science:
- Urology
- Public Health Advocacy
Background:
- Interstitial cystitis (IC) was historically misclassified as a rare, psychosomatic disorder affecting only post-menopausal women.
- Current understanding recognizes IC, now often termed bladder pain syndrome (BPS), as a prevalent condition affecting men, women, and children across all age groups.
- IC/BPS is no longer considered an orphan disease, with millions affected globally.
Purpose of the Study:
- To review the progress in understanding and managing interstitial cystitis (IC) over 30 years.
- To identify key factors contributing to the success of the Interstitial Cystitis Association of America (ICA) in advancing the condition's recognition and research.
- To provide insights for other patient advocacy groups.
Main Methods:
- Historical review of the perception and understanding of IC/BPS.
- Analysis of the Interstitial Cystitis Association of America's (ICA) 30-year history and its strategic initiatives.
- Identification of contributing factors to the ICA's success.
Main Results:
- Significant progress has been made in recognizing IC/BPS as a legitimate medical condition affecting diverse populations.
- Seven key factors contributed to the ICA's success: dedicated staff/volunteers, strong medical advisory board, media cooperation, epidemiological studies, research programs, congressional representation, and NIH partnership.
- The ICA's journey demonstrates a successful transition from limited understanding to widespread recognition and research support.
Conclusions:
- The evolution of IC/BPS understanding highlights the impact of dedicated advocacy and research.
- The success factors of the ICA offer a valuable model for other health advocacy organizations.
- Continued research and public awareness are crucial for improving outcomes for individuals with IC/BPS.